Coming soon to Athlete’s Foot - an innovative treatment that changes the game. Launching early 2025.​

Dermatologist working in a lab on propedix products

Propedix brings exceptional expertise in developing advanced topical dermatology formulations.

Our team has been instrumental in the R&D, formulation, and commercialization of renowned products such as Tazorac, Bellafill, Juvéderm, SkinPen, Zoryve and Aczone among others. Leveraging a proprietary technology platform, Propedix enhances the activation of traditional active ingredients, ensuring more effective delivery and improved compliance in topical treatments.  Our flagship product, featuring our breakthrough anti-fungal and drying agent technology, is an innovative treatment for Athlete’s Foot that’s set to launch in 2025.

Athlete’s foot is a common and persistent fungal infection affecting nearly one in five people worldwide.

Characterized by itching, redness, and cracked skin, this condition often recurs, as the fungus thrives in warm, moist environments like locker rooms, showers, and sweaty shoes. Despite frequent treatments, many individuals experience recurring bouts of athlete’s foot, underscoring the need for effective and convenient solutions. Our new product offers a powerful, easy-to-apply formula designed to target the root of the infection and help prevent future flare-ups, keeping feet healthy and comfortable year-round.